Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Downgrades Danaher to Hold

Benchmark Downgrades Danaher to Hold

Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.

byBenzinga Newsdesk

October 24, 2022

1 minute read

Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.

Citigroup Maintains Buy on Abbott Laboratories, Raises Price Target to $125

By Benzinga Newsdesk

December 12, 8:56 AM

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $114 to $125.

ABT

Coinbase Legal Setback: Court Rejects Motion To Dismiss SEC’s Securities Allegations

By Murtuza Merchant

March 27, 11:03 AM

Major setback for Coinbase as court rules against its motion to dismiss SEC lawsuit. Allegations of unregistered securities activity and staking program deemed unregistered security offering.

COIN

Qurate Retail Creates New Chief Transformation Officer Role; CFO Steps Down

By Shivani Kumaresan

August 24, 12:55 PM

Qurate Retail Group, part of Qurate Retail Inc (NASDAQ:QRTEA), said its Chief Financial Officer Jeffrey A. Davis has resigned from the company.…

QRTEA

Worried About Higher Interest Rates? Tesla Now Offers Auto Loans That You Can Pay Off In 7 Years.

By Shanthi Rexaline

July 22, 5:00 PM

Tesla. Inc. (NASDAQ:TSLA) CEO Elon Musk previously expressed concerns about the impact of rising interest rates on car…

TSLA

Benchmark Downgrades Danaher to Hold

Related Posts

Citigroup Maintains Buy on Abbott Laboratories, Raises Price Target to $125

Coinbase Legal Setback: Court Rejects Motion To Dismiss SEC’s Securities Allegations

Qurate Retail Creates New Chief Transformation Officer Role; CFO Steps Down

Worried About Higher Interest Rates? Tesla Now Offers Auto Loans That You Can Pay Off In 7 Years.